Clinical Biochemistry – Page 3 – Clinical Chemistry INFO

Best practice recommendations for laboratory analysis and reporting of cerebrospinal fluid oligoclonal banding and associated tests for multiple sclerosis (MS): a consensus report from the harmonized CSF analysis for MS investigation (hCAMI) subcommittee of the Canadian society of clinical chemists (CSCC)on February 17, 2026 at 10:29 am

February 17, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Victoria Higgins, Michelle L. Parker, Basma Ahmed, Vipin Bhayana, Ronald A. Booth, Yu Chen, Christine Collier, Mark S. Freedman, Myriam Gagné, Ola Z. Ismail, Jessica L. Gifford, Joseph Macri, Craig S. Moore, Ashley Newbigging, Lily Olayinka, Ilia Poliakov, Karina Rodriguez-Capote, Raphael Schneider, Simon Thebault, Liju … Read more

Inter-laboratory variability in vancomycin measurement in an external quality assessment scheme 2016–2025on February 15, 2026 at 2:23 pm

February 15, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Anders Larsson, Jonathan Cedernaes, Mats B. Eriksson, Anders Helldén, Moa Skarin, Päivi Ranta, Mathias Karlsson, Anna-Karin Hamberg

Application of thrombosis-related biomarkers in the diagnosis and thrombosis risk stratification of heparin-induced thrombocytopenia patientson February 10, 2026 at 3:14 pm

February 10, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Huiping Wang, Pengju Lv, Chenxue Qu, Shoukui Hu

Serum zinc, copper, and the Zn/Cu ratio across the glycemic spectrum: evidence from an automated clinical chemistry platformon February 10, 2026 at 3:14 pm

February 10, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Ufuk Sarıkaya, Şahabettin Selek, Alime Sarıkaya

Evidence-based extension of reagent shelf-life beyond expiry using patient-based moving averages, westgard sigma rules, and CLSI EP25on February 3, 2026 at 12:43 pm

February 3, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Mohamed Mokhtar Khelil, Tony Badrick

Silent electrolyte imbalance unmasked by paralysis: a case of hypokalemia in a middle-aged womanon January 30, 2026 at 2:37 pm

January 30, 2026 by ccinfoadmin

Publication date: March 2026 Source: Clinical Biochemistry, Volume 142 Author(s): Aman Advani, Hassan Ahmed, Muhammad Ahsan Shabbir, Maaz Ahmed, Tauqeer Khan

Fibroblast growth factor 23-induced hypophosphatemia in a malignant phosphaturic mesenchymal tumor: presentation of a rare caseon January 26, 2026 at 3:52 pm

January 26, 2026 by ccinfoadmin

Publication date: Available online 25 January 2026 Source: Clinical Biochemistry Author(s): Diver Alexis Chicangana Tuquerres, Andrés David Sastre Martinez, Carlos Mário Barrios Herrera, Paula Andrea Torres Pérez, Carlos Fernando Acuña Roldán, Gabriel Jaime Varela Aguirre, Andres Felipe García Ramos

The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucoseon January 25, 2026 at 2:32 pm

January 25, 2026 by ccinfoadmin

Publication date: Available online 24 January 2026 Source: Clinical Biochemistry Author(s): Daniel de Luis, Olatz Izaola, David Primo

Clinical Labs: Working with planetary health for patient healthon January 25, 2026 at 2:32 pm

January 25, 2026 by ccinfoadmin

Publication date: Available online 24 January 2026 Source: Clinical Biochemistry Author(s): Andre Mattman, Janet Simons

Acquired bisalbuminemia: A case reporton January 23, 2026 at 12:30 pm

January 23, 2026 by ccinfoadmin

Publication date: Available online 22 January 2026 Source: Clinical Biochemistry Author(s): R. Addesso, S. Sarpa, M. Ferrandino, C. Giorgione, A. Marrone, M. Savoia, G. Castaldo